Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vitamin K Antagonist”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02090543
What this trial is testing

BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies

Who this might be right for
Atrial Fibrillation
Bayer 647
Large-scale testing (Phase 3)Study completedNCT00618098
What this trial is testing

Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures

Who this might be right for
Reversal of Anticoagulant Treatment
Octapharma 200
Not applicableStudy completedNCT02687854
What this trial is testing

Real-world Comparative Effectiveness of Apixaban Versus Vitamin K Antagonist

Who this might be right for
Atrial Fibrillation
Bayer 18,591
Large-scale testing (Phase 3)Study completedNCT01674647
What this trial is testing

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

Who this might be right for
Atrial Fibrillation
Bayer 1,504
Testing effectiveness (Phase 2)WithdrawnNCT04002011
What this trial is testing

DOAC Versus VKA After Cardiac Surgery

Who this might be right for
Anticoagulant-induced Bleeding
Laval University
Not applicableStudy completedNCT02286414
What this trial is testing

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over

Who this might be right for
Atrial Fibrillation
Assistance Publique - Hôpitaux de Paris 159
Post-approval studies (Phase 4)Looking for participantsNCT07431762
What this trial is testing

Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprosthetic Heart Valve Replacement

Who this might be right for
Valve Replacement Surgery
Asan Medical Center 1,058
Testing effectiveness (Phase 2)Study completedNCT01533441
What this trial is testing

Vitamin K2 Intervention in Patients With Vitamin K Antagonists

Who this might be right for
Thrombosis
Danisco 50
Not applicableStudy completedNCT04297072
What this trial is testing

Study to Gather Information on the Kidney Function of Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem) Treated With Rivaroxaban or Vitamin K Antagonists

Who this might be right for
Non-Valvular Atrial Fibrillation
Bayer 25,000
Large-scale testing (Phase 3)Looking for participantsNCT03636295
What this trial is testing

Low INR to Minimize Bleeding With Mechanical Valves Trial

Who this might be right for
Bleeding Post-mechanical Valve ReplacementThromboembolism Post-mechanical Valve Replacement
Population Health Research Institute 2,625
Post-approval studies (Phase 4)Active Not RecruitingNCT03129490
What this trial is testing

The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation

Who this might be right for
Atrial FibrillationAtrial Flutter
Herlev and Gentofte Hospital 11,000
Not applicableStudy completedNCT03085576
What this trial is testing

NATional TUnisian REgistry of Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Dacima Consulting 910
Not applicableStudy completedNCT04062097
What this trial is testing

Registration of Idarucizumab for Patients with IntraCranial Hemorrhage

Who this might be right for
Intracranial Hemorrhage
University Hospital, Essen 104
Large-scale testing (Phase 3)WithdrawnNCT02832531
What this trial is testing

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority

Who this might be right for
Rheumatic Heart Disease
Population Health Research Institute
Post-approval studies (Phase 4)Not Yet RecruitingNCT07496281
What this trial is testing

OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation

Who this might be right for
Atrial Fibrillation (AF)Coronary Artery DiseaseDrug-eluting Stent
Ewha Womans University Mokdong Hospital 2
Large-scale testing (Phase 3)Study completedNCT01130025
What this trial is testing

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

Who this might be right for
Venous Thromboembolism
LEO Pharma 900
Not applicableNot Yet RecruitingNCT07146282
What this trial is testing

Vitamin K Antagonist in Rheumatic Heart Disease Patients With Mechanical Heart Valves: Our Current Status

Who this might be right for
Rheumatic Heart Disease
Ahmed Hassan Rostom Ibrahim 165
Large-scale testing (Phase 3)Study completedNCT00803101
What this trial is testing

An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure

Who this might be right for
Reversal of Coagulopathy
CSL Behring 176
Not applicableLooking for participantsNCT07658989
What this trial is testing

Optimizing Anticoagulation in Pregnancies With Mechanical Heart Valves

Who this might be right for
PregnancyProsthetic Heart ValveAnticoagulant Therapy
Mount Sinai Hospital, Canada 100
Large-scale testing (Phase 3)Study completedNCT00070655
What this trial is testing

Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)

Who this might be right for
Atrial Fibrillation
Sanofi 4,673
Next Page